Revenue: The sum of all revenue fields included for a company's operating activities.
Zevra Therapeutics, Inc. (ZVRA) had Revenue of $25.88M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$25.88M |
$67.91M |
|
$12.38M |
|
$13.50M |
|
$96.92M |
|
$-71.04M |
|
$147.94M |
|
$76.91M |
|
$76.91M |
|
$74.71M |
|
$74.71M |
|
$74.71M |
|
$74.71M |
|
$-71.04M |
|
$-11.43M |
|
54.78M |
|
56.33M |
|
$1.24 |
|
$1.21 |
|
| Balance Sheet Financials | |
$226.34M |
|
$0.60M |
|
$29.94M |
|
$256.28M |
|
$28.83M |
|
$60.69M |
|
$110.22M |
|
$139.05M |
|
$117.23M |
|
$105.48M |
|
$117.23M |
|
55.08M |
|
| Cash Flow Statement Financials | |
$-11.82M |
|
$22.48M |
|
$2.99M |
|
$33.78M |
|
$47.71M |
|
$13.93M |
|
$5.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.85 |
|
-- |
|
-- |
|
0.34 |
|
0.52 |
|
52.17% |
|
-274.48% |
|
-274.48% |
|
-- |
|
297.15% |
|
262.39% |
|
$-12.13M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
11.17 |
|
1.42 |
|
63.52 |
|
63.73% |
|
70.83% |
|
29.15% |
|
41.99% |
|
$2.13 |
|
$-0.22 |
|
$-0.21 |
|